Relapsed malignant pleural mesothelioma: An impressive response to Nivolumab monotherapy S. Costa-Martins; I. Vicente; S. Valente;

Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients A. Arrobas; M.P. Barbosa; S. Rabiais; B. Vandewalle; J. Félix;